Carlsmed (CARL) Total Liabilities (2024 - 2026)

Carlsmed (CARL) has 3 years of Total Liabilities data on file, last reported at $26.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 65.38% year-over-year to $26.5 million; the trailing twelve-month figure through Mar 2026 stood at $26.5 million (down 65.38% YoY), and the FY2025 full-year result was $31.3 million, up 19.15% from the prior year.
• Total Liabilities for Q1 2026 stood at $26.5 million, down from $31.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $76.6 million in Q1 2025 and bottomed at $26.2 million in Q4 2024.
• The 3-year median for Total Liabilities is $29.7 million (2025), against an average of $42.5 million.
• The widest annual swing landed in 2025, when Total Liabilities grew 19.15%; it then plunged 65.38% in 2026.
• A 3-year view of Total Liabilities shows it stood at $26.2 million in 2024, then grew by 19.15% to $31.3 million in 2025, then declined by 15.14% to $26.5 million in 2026.
• The last three Total Liabilities figures came in at $26.5 million (Q1 2026), $31.3 million (Q4 2025), and $28.2 million (Q3 2025), per Business Quant data.

Peer Comparison